Letter date: 9 April 2010
Invitation to review and provide comments on the draft risk management evaluation on endosulfan and to submit additional information (adverse human health effects, costs and benefits of implementing control measures, and alternatives)
Deadline to submit comments on draft RME: 25 May 2010
Deadline to submit additional information: 10 June 2010
Read more